Key publication
890
Therapeutic Areas
Methods & challenges

Key publication

The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant.

Key publication

Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.

Key publication

The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.

Key publication

Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.

12 February 2024

Biologicals : journal of the International Association of Biological Standardization

Read Publication

Key publication

Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting report.

2 February 2024

Biologicals : journal of the International Association of Biological Standardization

Read Publication

Key publication

Disproportional inflation of clinical trial costs: why we should care, and what we should do about it.

Key publication

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.

Key publication

Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne.

Key publication

A phase 1 trial of AP30663, a K 2 channel inhibitor in development for conversion of atrial fibrillation.